The trademark application EPISTATUS MDB was filed by Veriton Pharma Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on May 3, 2023, and it was registered by office on August 10, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).